Next Article in Journal
Fabrication of Ciprofloxacin-Loaded Sodium Alginate Nanobeads Coated with Thiol-Anchored Chitosan Using B-390 Encapsulator Following Optimization by DoE
Next Article in Special Issue
Antitumoral-Embedded Biopolymeric Spheres for Implantable Devices
Previous Article in Journal
Development of a Web Application for Simulating Plasma Drug Concentrations in Patients with Zolpidem Intoxication
Previous Article in Special Issue
Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 16
Issue 5
10.3390/pharmaceutics16050690
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Pharmaceutics 2021, 13(5), 693.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Zaman et al. Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications. Pharmaceutics 2021, 13, 693

by
Muhammad Zaman
1,*,
Sadaf Saeed
2,
Rabia Imtiaz Bajwa
2,
Muhammad Shafeeq Ur Rahman
1,
Saeed Ur Rahman
3,
Muhammad Jamshaid
1,
Muhammad F. Rasool
4,
Abdul Majeed
4,
Imran Imran
5,
Faleh Alqahtani
6,*,
Sultan Alshehri
7,
Abdullah F. AlAsmari
6,
Nemat Ali
6 and
Mohammed S. Alasmari
6
1
Faculty of Pharmacy, University of Central Punjab, Lahore 54000, Pakistan
2
Department of Pharmaceutics, Faculty of Pharmacy, The University of Lahore, Lahore 54000, Pakistan
3
Oral Biology, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar 59000, Pakistan
4
Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan
5
Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan
6
Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
7
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2024, 16(5), 690; https://doi.org/10.3390/pharmaceutics16050690
Submission received: 31 May 2023 / Accepted: 7 April 2024 / Published: 20 May 2024
(This article belongs to the Special Issue Polymers Enhancing Bioavailability in Drug Delivery)
Browse Figure
Versions Notes

Author Name Correction

In the original publication, there was a mistake in one author name, Mohammed Alasmari should be Mohammed S. Alasmari. And accordingly, in the author contributions part, M.A. should be M.S.A.

Error in Figure

In the original publication, there was a mistake in Figure 6 as published [1]. Unfortunately, the data were not assembled correctly. Now, the below-mentioned Figure 6 is the correct one.

Text Correction

In the original publication, there was a mistake in Section 2.3.7 as published [1]. Unfortunately, by mistake, the information (JSM-6490A, Tokyo, Japan) related to the used instruments is not correct. The correct information is EVO LS 10 Zeiss, Germany.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Zaman, M.; Saeed, S.; Imtiaz Bajwa, R.; Shafeeq Ur Rahman, M.; Rahman, S.U.; Jamshaid, M.; Rasool, M.F.; Majeed, A.; Imran, I.; Alqahtani, F.; et al. Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications. Pharmaceutics 2021, 13, 693. [Google Scholar] [CrossRef] [PubMed]
Pharmaceutics 16 00690 g006
Figure 6. Histopathological evaluation of control group, PLX-treated group, and TPLX-treated group, illustrating the safety profile of modified and unmodified polymers. All the vital organs had normal physiological and anatomical features.
Figure 6. Histopathological evaluation of control group, PLX-treated group, and TPLX-treated group, illustrating the safety profile of modified and unmodified polymers. All the vital organs had normal physiological and anatomical features.
Pharmaceutics 16 00690 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zaman, M.; Saeed, S.; Imtiaz Bajwa, R.; Shafeeq Ur Rahman, M.; Rahman, S.U.; Jamshaid, M.; Rasool, M.F.; Majeed, A.; Imran, I.; Alqahtani, F.; et al. Correction: Zaman et al. Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications. Pharmaceutics 2021, 13, 693. Pharmaceutics 2024, 16, 690. https://doi.org/10.3390/pharmaceutics16050690

AMA Style

Zaman M, Saeed S, Imtiaz Bajwa R, Shafeeq Ur Rahman M, Rahman SU, Jamshaid M, Rasool MF, Majeed A, Imran I, Alqahtani F, et al. Correction: Zaman et al. Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications. Pharmaceutics 2021, 13, 693. Pharmaceutics. 2024; 16(5):690. https://doi.org/10.3390/pharmaceutics16050690

Chicago/Turabian Style

Zaman, Muhammad, Sadaf Saeed, Rabia Imtiaz Bajwa, Muhammad Shafeeq Ur Rahman, Saeed Ur Rahman, Muhammad Jamshaid, Muhammad F. Rasool, Abdul Majeed, Imran Imran, Faleh Alqahtani, and et al. 2024. "Correction: Zaman et al. Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications. Pharmaceutics 2021, 13, 693" Pharmaceutics 16, no. 5: 690. https://doi.org/10.3390/pharmaceutics16050690

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop